{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:06:58Z","timestamp":1792789618877,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Alzheimer's Research UK"},{"name":"Bill Brown Charitable Trust","award":["Senior Research Fellowship"],"award-info":[{"award-number":["Senior Research Fellowship"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13195-019-0516-x","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T19:02:36Z","timestamp":1563476556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1476-5568","authenticated-orcid":false,"given":"Jurre","family":"den Haan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos","family":"Csinscik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross W.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine F.","family":"Slattery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Foulkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke H.","family":"Bouwman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank D.","family":"Verbraak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunde","family":"Peto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian J.","family":"Crutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Shakespeare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keir X. X.","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,18]]},"reference":[{"issue":"1","key":"516_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","volume":"9","author":"A London","year":"2013","unstructured":"London A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol. 2013;9(1):44\u201353.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"516_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2217\/nmt-2017-0030","volume":"8","author":"VS Pelak","year":"2018","unstructured":"Pelak VS, Hills W. Vision in Alzheimer\u2019s disease: a focus on the anterior afferent pathway. Neurodegener Dis Manag. 2018;8(1):49\u201367.","journal-title":"Neurodegener Dis Manag"},{"issue":"6","key":"516_CR3","first-page":"162","volume":"2017","author":"J den Haan","year":"2017","unstructured":"den Haan J, et al. Retinal thickness in Alzheimer\u2019s disease: a systematic review and meta-analysis. Alzheimers Dement. 2017;2017(6):162\u201370.","journal-title":"Alzheimers Dement"},{"key":"516_CR4","doi-asserted-by":"crossref","unstructured":"Chan VTT, et al. Spectral domain-optical coherence tomography measurements in Alzheimer\u2019s disease: a systematic review and meta-analysis. Ophthalmology. 2018;126:497\u2013510.","DOI":"10.1016\/j.ophtha.2018.08.009"},{"key":"516_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.dadm.2016.11.001","volume":"6","author":"S McGrory","year":"2017","unstructured":"McGrory S, et al. The application of retinal fundus camera imaging in dementia: a systematic review. Alzheimers Dement (Amst). 2017;6:91\u2013107.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"SUPPL. 1","key":"516_CR6","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui M, et al. Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. NeuroImage. 2011;54(SUPPL. 1):S204\u201317.","journal-title":"NeuroImage"},{"issue":"12","key":"516_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0053547","volume":"7","author":"C Sch\u00f6n","year":"2012","unstructured":"Sch\u00f6n C, et al. Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. PLoS One. 2012;7(12):1\u20139.","journal-title":"PLoS One"},{"issue":"6","key":"516_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00401-016-1609-2","volume":"132","author":"BM Davis","year":"2016","unstructured":"Davis BM, et al. Glaucoma: the retina and beyond. Acta Neuropathol. 2016;132(6):807\u201326.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"516_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1001\/jamaneurol.2018.0602","volume":"75","author":"SS Ong","year":"2018","unstructured":"Ong SS, Doraiswamy PM, Lad EM. Controversies and future directions of ocular biomarkers in Alzheimer disease. JAMA Neurol. 2018;75(6):650\u20131.","journal-title":"JAMA Neurol"},{"issue":"8","key":"516_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrneurol.2012.135","volume":"8","author":"JD Warren","year":"2012","unstructured":"Warren JD, Fletcher PD, Golden HL. The paradox of syndromic diversity in Alzheimer disease. Nat Rev Neurol. 2012;8(8):451\u201364.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"516_CR11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jalz.2017.01.014","volume":"13","author":"SJ Crutch","year":"2017","unstructured":"Crutch SJ, et al. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 2017;13(8):870\u201384.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"516_CR12","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.neurobiolaging.2009.08.017","volume":"32","author":"M Lehmann","year":"2011","unstructured":"Lehmann M, et al. Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer\u2019s disease. Neurobiol Aging. 2011;32(8):1466\u201376.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"516_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1212\/WNL.0b013e31825dce28","volume":"79","author":"GR Ridgway","year":"2012","unstructured":"Ridgway GR, et al. Early-onset Alzheimer disease clinical variants: multivariate analyses of cortical thickness. Neurology. 2012;79(1):80\u20134.","journal-title":"Neurology"},{"issue":"3","key":"516_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"516_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000058331","volume":"14","author":"MF Mendez","year":"2002","unstructured":"Mendez MF, Ghajarania M, Perryman KM. Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2002;14(1):33\u201340.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"7","key":"516_CR16","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1212\/01.WNL.0000140289.18472.15","volume":"63","author":"DF Tang-Wai","year":"2004","unstructured":"Tang-Wai DF, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology. 2004;63(7):1168\u201374.","journal-title":"Neurology"},{"key":"516_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1\u201310.","journal-title":"Neurology"},{"issue":"6","key":"516_CR18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614\u201329.","journal-title":"Lancet Neurol"},{"issue":"3","key":"516_CR19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31(3):968\u201380.","journal-title":"Neuroimage"},{"issue":"3","key":"516_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33(3):341\u201355.","journal-title":"Neuron"},{"issue":"3","key":"516_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/cercor\/bhn113","volume":"19","author":"BC Dickerson","year":"2009","unstructured":"Dickerson BC, et al. The cortical signature of Alzheimer\u2019s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2009;19(3):497\u2013510.","journal-title":"Cereb Cortex"},{"issue":"2","key":"516_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","volume":"6","author":"GB Frisoni","year":"2010","unstructured":"Frisoni GB, et al. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 2010;6(2):67\u201377.","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"516_CR23","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1002\/hbm.22927","volume":"36","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele R, et al. Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer\u2019s disease. Hum Brain Mapp. 2015;36(11):4421\u201337.","journal-title":"Hum Brain Mapp"},{"issue":"19","key":"516_CR24","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1001\/jama.2015.4669","volume":"313","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele R, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA. 2015;313(19):1939\u201349.","journal-title":"JAMA"},{"key":"516_CR25","unstructured":"Zwan, M.D., et al., Diagnostic impact of [18F] flutemetamol amyloid imaging in young-onset dementia. Alzheimer Dement Res Ther. 2017. In Press."},{"issue":"6","key":"516_CR26","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1159\/000339367","volume":"33","author":"CG Schipke","year":"2012","unstructured":"Schipke CG, et al. Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2012;33(6):416\u201322.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"516_CR27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.dadm.2015.10.001","volume":"1","author":"PS Weston","year":"2015","unstructured":"Weston PS, et al. Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes. Alzheimers Dement (Amst). 2015;1(4):440\u20136.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"4","key":"516_CR28","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3233\/JAD-2010-1337","volume":"19","author":"EL Koedam","year":"2010","unstructured":"Koedam EL, et al. Early-versus late-onset Alzheimer\u2019s disease: more than age alone. J Alzheimers Dis. 2010;19(4):1401\u20138.","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"516_CR29","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00234-007-0269-2","volume":"49","author":"G Karas","year":"2007","unstructured":"Karas G, et al. Precuneus atrophy in early-onset Alzheimer\u2019s disease: a morphometric structural MRI study. Neuroradiology. 2007;49(12):967\u201376.","journal-title":"Neuroradiology"},{"key":"516_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/jnnp.2003.029876","volume":"76","author":"GB Frisoni","year":"2004","unstructured":"Frisoni GB, et al. Structural correlates of early and late onset Alzheimer\u2019s disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry. 2004;76:112\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"516_CR31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.dadm.2017.10.005","volume":"10","author":"J den Haan","year":"2018","unstructured":"den Haan J, et al. Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer\u2019s disease and controls. Alzheimers Dement (Amst). 2018;10:49\u201355.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"5","key":"516_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/1533317515628053","volume":"31","author":"Jagan A. Pillai","year":"2016","unstructured":"Pillai JA, et al. Retinal nerve fiber layer thinning in Alzheimer\u2019s disease: a case-control study in comparison to Normal aging, Parkinson's disease, and non-Alzheimer's dementia. Am J Alzheimers Dis Other Dement. 2016;31:430\u201336.","journal-title":"American Journal of Alzheimer's Disease & Other Dementiasr"},{"issue":"1","key":"516_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jalz.2018.06.2856","volume":"15","author":"Cecilia S. Lee","year":"2019","unstructured":"Lee CS, et al. Associations between recent and established ophthalmic conditions and risk of Alzheimer\u2019s disease. Alzheimers Dement. 2018;15:34\u201341.","journal-title":"Alzheimer's & Dementia"},{"issue":"6","key":"516_CR34","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ajo.2010.06.025","volume":"150","author":"A Giani","year":"2010","unstructured":"Giani A, et al. Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. Am J Ophthalmol. 2010;150(6):815\u201324.","journal-title":"Am J Ophthalmol"},{"key":"516_CR35","first-page":"463","volume":"11","author":"JD Haan","year":"2019","unstructured":"Haan JD, et al. Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer\u2019s disease. Alzheimers Dement. 2019;11:463\u201371.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"516_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000070634","volume":"217","author":"A Kanamori","year":"2003","unstructured":"Kanamori A, et al. Evaluation of the effect of aging on retinal nerve fiber layer thickness measured by optical coherence tomography. Ophthalmologica. 2003;217(4):273\u20138.","journal-title":"Ophthalmologica"},{"issue":"7","key":"516_CR37","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1167\/iovs.13-11913","volume":"54","author":"N Demirkaya","year":"2013","unstructured":"Demirkaya N, et al. Effect of age on individual retinal layer thickness in normal eyes as measured with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54(7):4934\u201340.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"516_CR38","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1167\/iovs.11-8997","volume":"53","author":"HW van Dijk","year":"2012","unstructured":"van Dijk HW, et al. Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci. 2012;53(6):2715\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"516_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.visres.2017.03.003","volume":"139","author":"SK Lynch","year":"2017","unstructured":"Lynch SK, Abramoff MD. Diabetic retinopathy is a neurodegenerative disorder. Vis Res. 2017;139:101\u20137.","journal-title":"Vis Res"},{"issue":"19","key":"516_CR40","doi-asserted-by":"publisher","first-page":"E2655","DOI":"10.1073\/pnas.1522014113","volume":"113","author":"EH Sohn","year":"2016","unstructured":"Sohn EH, et al. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci U S A. 2016;113(19):E2655\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"516_CR41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.22336\/rjo.2017.45","volume":"61","author":"AG Dumitrescu","year":"2017","unstructured":"Dumitrescu AG, et al. Retinal changes in diabetic patients without diabetic retinopathy. Rom J Ophthalmol. 2017;61(4):249\u201355.","journal-title":"Rom J Ophthalmol"},{"issue":"2","key":"516_CR42","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/02713683.2017.1387669","volume":"43","author":"R Shi","year":"2018","unstructured":"Shi R, et al. Alterations in retinal nerve fiber layer thickness in early stages of diabetic retinopathy and potential risk factors. Curr Eye Res. 2018;43(2):244\u201353.","journal-title":"Curr Eye Res"},{"issue":"2","key":"516_CR43","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/aos.13570","volume":"96","author":"EEB De Clerck","year":"2018","unstructured":"De Clerck EEB, et al. Macular thinning in prediabetes or type 2 diabetes without diabetic retinopathy: the Maastricht study. Acta Ophthalmol. 2018;96(2):174\u201382.","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"516_CR44","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/OPX.0000000000001256","volume":"95","author":"L Nivison-Smith","year":"2018","unstructured":"Nivison-Smith L, et al. Retinal thickness changes throughout the natural history of Drusen in age-related macular degeneration. Optom Vis Sci. 2018;95(8):648\u201355.","journal-title":"Optom Vis Sci"},{"issue":"10","key":"516_CR45","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jamaophthalmol.2015.2453","volume":"133","author":"SH Lee","year":"2015","unstructured":"Lee SH, Lee EJ, Kim TW. Structural characteristics of the acquired optic disc pit and the rate of progressive retinal nerve fiber layer thinning in primary open-angle glaucoma. JAMA Ophthalmol. 2015;133(10):1151\u20138.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"516_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085718","volume":"9","author":"JG Yu","year":"2014","unstructured":"Yu JG, et al. Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS One. 2014;9(1):e85718.","journal-title":"PLoS One"},{"issue":"10","key":"516_CR47","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","volume":"16","author":"A Petzold","year":"2017","unstructured":"Petzold A, et al. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2017;16(10):797\u2013812.","journal-title":"Lancet Neurol"},{"issue":"7","key":"516_CR48","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, et al. CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15(7):673\u201384.","journal-title":"Lancet Neurol"},{"key":"516_CR49","doi-asserted-by":"crossref","unstructured":"Koronyo Y, et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight. 2017;2(16):e93621.","DOI":"10.1172\/jci.insight.93621"},{"issue":"5","key":"516_CR50","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/jnen\/nlx020","volume":"76","author":"EA Williams","year":"2017","unstructured":"Williams EA, et al. Absence of Alzheimer disease neuropathologic changes in eyes of subjects with Alzheimer disease. J Neuropathol Exp Neurol. 2017;76(5):376\u201383.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"516_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/bpa.12070","volume":"24","author":"CY Ho","year":"2014","unstructured":"Ho CY, et al. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer\u2019s and Parkinson\u2019s disease patients. Brain Pathol. 2014;24(1):25\u201332.","journal-title":"Brain Pathol"},{"issue":"6","key":"516_CR52","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/brain\/awx088","volume":"140","author":"MF Cordeiro","year":"2017","unstructured":"Cordeiro MF, et al. Real-time imaging of single neuronal cell apoptosis in patients with glaucoma. Brain. 2017;140(6):1757\u201367.","journal-title":"Brain"},{"issue":"2","key":"516_CR53","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1167\/iovs.15-17961","volume":"57","author":"R Sharma","year":"2016","unstructured":"Sharma R, et al. Two-photon autofluorescence imaging reveals cellular structures throughout the retina of the living primate eye. Invest Ophthalmol Vis Sci. 2016;57(2):632\u201346.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"516_CR54","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1364\/BOE.6.001055","volume":"6","author":"S He","year":"2015","unstructured":"He S, et al. Label-free nonlinear optical imaging of mouse retina. Biomed Opt Express. 2015;6(3):1055\u201366.","journal-title":"Biomed Opt Express"},{"key":"516_CR55","volume-title":"Hyperspectral imaging signatures detect amyloidopathy in Alzheimer\u2019s mouse retina well before onset of cognitive decline","author":"SS More","year":"2014","unstructured":"More SS, Vince R. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer\u2019s mouse retina well before onset of cognitive decline; 2014."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0516-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-019-0516-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0516-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T07:00:08Z","timestamp":1610521208000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-019-0516-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,18]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["516"],"URL":"https:\/\/doi.org\/10.1186\/s13195-019-0516-x","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,18]]},"assertion":[{"value":"21 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was provided by the National Research Ethics Service Committee London Queen Square; all participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}